We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,884
Increased
5,796
Reduced
5,769
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEL icon
10226
CALL
Velocity Financial
VEL
$694M
$413K ﹤0.01%
+31,400
New +$400K
YCS icon
10227
PUT
ProShares UltraShort Yen
YCS
$29.4M
$413K ﹤0.01%
+21,200
New +$405K
ZYNE
10228
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$413K ﹤0.01%
97,300
-15,300
-14% -$68.3K
CLAA.WS
10229
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$413K ﹤0.01%
510,069
+70
+0% +$66
ACRS icon
10230
PUT
Aclaris Therapeutics
ACRS
$888M
$412K ﹤0.01%
22,900
+12,500
+120% +$200K
PLMR icon
10231
PUT
Palomar
PLMR
$3.55B
$412K ﹤0.01%
5,100
-200
-4% -$16.5K
REK icon
10232
ProShares Short Real Estate
REK
$11.7M
$412K ﹤0.01%
22,443
+1,100
+5% +$19.6K
SRET icon
10233
Global X SuperDividend REIT ETF
SRET
$230M
$412K ﹤0.01%
14,450
+2,294
+19% +$67.1K
TMC icon
10234
TMC The Metals Company
TMC
$1.74B
$412K ﹤0.01%
90,077
-654,438
-88% -$6.25M
TRONW
10235
DELISTED
Corner Growth Acquisition Corp. 2 Warrants
TRONW
$412K ﹤0.01%
+400,299
New +$396K
SJR
10236
CALL
DELISTED
Shaw Communications Inc.
SJR
$412K ﹤0.01%
14,200
+4,600
+48% +$133K
CBU icon
10237
CALL
Community Bank
CBU
$3.48B
$411K ﹤0.01%
6,000
-4,200
-41% -$301K
HMC icon
10238
PUT
Honda
HMC
$39.7B
$411K ﹤0.01%
13,400
+1,700
+15% +$53.5K
OPLN
10239
PUT
Openlane
OPLN
$4.05B
$411K ﹤0.01%
25,100
-3,500
-12% -$59K
PSMT icon
10240
CALL
Pricesmart
PSMT
$5.76B
$411K ﹤0.01%
5,300
-2,300
-30% -$195K
TILE icon
10241
Interface
TILE
$2.04B
$411K ﹤0.01%
27,117
WLKP icon
10242
CALL
Westlake Chemical Partners
WLKP
$750M
$411K ﹤0.01%
16,900
-11,400
-40% -$298K
ECOM
10243
CALL
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$411K ﹤0.01%
16,300
+4,400
+37% +$108K
CATO icon
10244
CALL
Cato Corp
CATO
$68.5M
$410K ﹤0.01%
24,800
+5,700
+30% +$95.2K
LAB icon
10245
Standard BioTools
LAB
$307M
$410K ﹤0.01%
62,153
-34,379
-36% -$226K
NPCE icon
10246
Neuropace
NPCE
$467M
$410K ﹤0.01%
+25,822
New +$542K
BDSX icon
10247
Biodesix
BDSX
$236M
$409K ﹤0.01%
2,485
-221
-8% -$41.9K
CCC
10248
CALL
CCC Intelligent Solutions
CCC
$3.8B
$409K ﹤0.01%
38,900
+8,400
+28% +$86.8K
FDIS icon
10249
CALL
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.73B
$409K ﹤0.01%
5,100
-100
-2% -$8.2K
NPO icon
10250
CALL
Enpro
NPO
$6.94B
$409K ﹤0.01%
+4,700
New +$413K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.